Efficacy and Safety of SPC1001 in Patients With Essential Hypertension

Clinical trial NCT06826872 · RECRUITING

Trial details

NCT number: NCT06826872
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Essential Cardiovascular Diseases Cardiology

Start date: 2024-06-12
Primary completion: 2025-10-08
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.